(ARA) – A common complication of diabetes is the development of nerve damage, also known as diabetic nerve pain. This damage affects the nerves that allow patients to feel sensations such as numbness and debilitating pain – also called neuropathy.
When high blood sugar levels damage nerves, diabetic neuropathy can occur and eventually 40 to 60 percent of diabetics will develop diabetic nerve pain. Mostly it affects the hands and feet, with mild to severe numbness, and sharp pain like pins and needles. Limbs feel alternately burning hot and icy cold, accompanied by pain and muscle fatigue.
Neuragen, a topical ointment made by Origin BioMed Inc., is one of the leading non-prescription nerve pain treatments in North America. Neuragen has been recommended by health care professionals in the United States and Canada since 1996 for treatments of chronic pain associated with a variety of conditions. In three clinical trials, it provided rapid and effective pain relief without significant side effects.
Neuragen is now available at all leading drugstores across the country. The increased availability of this effective treatment option is welcome news for patients. More information on Neuragen and nerve pain is available at www.neuragen.com.